Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$488K Sell
2,926
-105
-3% -$18.7K 0.36% 43
2024
Q3
$516K Sell
3,031
-79
-3% -$11.4K 0.4% 43
2024
Q2
$439K Sell
3,110
-32
-1% -$3.97K 0.36% 48
2024
Q1
$395K Buy
3,142
+60
+2% +$6.87K 0.33% 51
2023
Q4
$325K Sell
3,082
-137
-4% -$15K 0.29% 55
2023
Q3
$341K Sell
3,219
-76
-2% -$8.8K 0.32% 53
2023
Q2
$392K Sell
3,295
-136
-4% -$14.1K 0.36% 49
2023
Q1
$319K Buy
3,431
+163
+5% +$14.3K 0.3% 58
2022
Q4
$267K Buy
+3,268
New +$248K 0.27% 65
2022
Q3
Sell
-3,397
Closed -$237K 76
2022
Q2
$237K Buy
3,397
+567
+20% +$41.5K 0.26% 69
2022
Q1
$234K Sell
2,830
-174
-6% -$14.1K 0.22% 77
2021
Q4
$262K Buy
+3,004
New +$282K 0.25% 76

Other funds holding ORCL

Unionview LLC's ORCL Position: Q4 2024 in Review

Unionview LLC reduced its Oracle (ORCL) stake by 3.5% in Q4 2024, selling an estimated $18.7K and leaving 2,926 shares worth $488K. The position accounts for 0.36% of the portfolio, ranked #43.

Unionview LLC first reported a position in ORCL in Q4 2021 and has held it in 12 quarters since. The position peaked at $516K in Q3 2024. 3,343 funds tracked by Wall St. Rank hold ORCL as of Q4 2024.

  • Unionview LLC held 2,926 shares of Oracle worth $488K as of Q4 2024.
  • Unionview LLC sold 105 Oracle shares in Q4 2024, an estimated $18.7K.
  • Oracle made up 0.36% of Unionview LLC's portfolio in Q4 2024, its #43 holding.
  • Unionview LLC first reported a position in Oracle in Q4 2021 and has held it in 12 quarters since.
  • Unionview LLC's Oracle position peaked at $516K in Q3 2024.
  • 3,343 funds tracked by Wall St. Rank held Oracle as of Q4 2024.

Based on Unionview LLC's 13F filing for Q4 2024, filed 3 Feb 2025.